Heike Seifert

Tunable-Combinatorial Mechanisms of Acquired Resistance Limit the Efficacy of BRAF/MEK Cotargeting but Result in Melanoma Drug Addiction

Gatien Moriceau, Willy Hugo, Aayoung Hong et al. · Cancer Cell · 2015 · 345 citations · Full text

Melanoma Drug Addiction, Braf/mek Cotargeting, Medicine +9

Phase I dose-escalation study of the protein kinase C (PKC) inhibitor AEB071 in patients with metastatic uveal melanoma.

Sophie Piperno‐Neumann, Ellen Kapiteijn, James Larkin et al. · Journal of Clinical Oncology · 2014 · 54 citations

Immunology, Immunotherapeutics, Dermatology +17

Extrinsic factors can mediate resistance to <scp>BRAF</scp> inhibition in central nervous system melanoma metastases

Heike Seifert, Eishu Hirata, Martin Gore et al. · Pigment Cell & Melanoma Research · 2015 · 46 citations · Full text

Immunology, Braf Inhibitor Resistance, Pathology +16

Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study

Alexander Siebenhüner, Heike Seifert, Helga Bachmann et al. · BMC Cancer · 2018 · 36 citations · Full text

Frequency of Colorectal Polyps in Patients with Sporadic Adenomas or Adenocarcinomas of the Papilla of Vater - An Age-Matched, Controlled Study

A Schneider, Heike Seifert, Jörg Trojan et al. · Zeitschrift für Gastroenterologie · 2005 · 18 citations